Utama › Pendarahan › Missouri
Kajian klinikal Pendarahan di Missouri
8 kajian untuk Pendarahan sedang mencari peserta di lokasi di Missouri.
Bandar di Missouri
Teks kajian rasmi (Bahasa Inggeris)
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
- University of Missouri Health Care, Columbia
Mengambil pesertaFasa 2
Umur 18 hingga 90 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05958342A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- MidAmerica Cancer Center, Kansas City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- MidAmerica Cancer Center, Kansas City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06948318Auricular VNS Following Intracerebral Hemorrhage
- Washington University School of Medicine, St Louis
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT06799390A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
- Washington University, St Louis
Mengambil pesertaFasa 3
1 Month · Semua jantina · Dikemas kini 30 Jun 2026 · NCT06664775Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Mid America Health Institute, Kansas City
- Washington University School of Medicine, St Louis
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Jun 2026 · NCT04045665Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- Children's Hospital St. Louis, St Louis
Mengambil pesertaFasa 2/3
Sehingga umur 17 · Semua jantina · Dikemas kini 8 Jun 2026 · NCT04924322Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU
- Washington University School of Medicine, St Louis
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Okt 2025 · NCT07219108Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.